Table 2. hCG concentration from individual samples of GTD-hCG.
| Patient Id. (Molar pregnancy) | Time from evacuation (days) | Sample hCG (IU/L) | [hCG] after purification (mg/L) | Histology (Mole type) | Benign or Malignant? |
|---|---|---|---|---|---|
| GTD-hCG1 | 0 | 693492 | 1297 | CHM | Benign |
| GTD-hCG2 | 0 | 1276646 | 2978 | CHM | Benign |
| GTD-hCG3 | 0 | 64448 | 361 | CHM | Benign |
| GTD-hCG4* | 0 | 7704768 | 11544 | CHM | Malignant |
Details of urine samples collected from patients suffering molar pregnancy. All molar pregnancies were subsequently histologically diagnosed as complete moles (CHM).
* Patient identity GTD-hCG4 had persistent trophoblastic neoplasia requiring multiagent chemotherapy to achieve normalisation of serum hCG and disease resolution.